array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(14) "ELEKTA LIMITED"
["slug"]=>
string(23) "dbe4b-gb-elekta-limited"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/03cdfb0f-1bfc-426b-afae-aad1f451dee7"
["description"]=>
string(735) "At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm. Visit elekta.com to learn more."
["address_street"]=>
string(11) "Linac House"
["address_place"]=>
string(7) "CRAWLEY"
["address_region"]=>
NULL
["founding_date"]=>
string(10) "1996-09-02"
["website_domain"]=>
string(10) "elekta.com"
["website_url"]=>
string(22) "https://www.elekta.com"
["industry_codes"]=>
array(1) {
[0]=>
string(46) "Surgical and Medical Instruments and Apparatus"
}
["employee_count"]=>
int(820)
["article_count"]=>
int(553)
}
["articles"]=>
array(3) {
[0]=>
array(7) {
["title_en"]=>
string(50) "Elekta receives $40M radiation tech order in India"
["snippet_en"]=>
string(125) "Elekta announced today that it received an order worth approximately $40 million for its full suite of hardware and software."
["url"]=>
string(69) "https://www.massdevice.com/elekta-receives-40m-radiation-order-india/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/fda59af0-8699-4161-b670-8dec215e7078"
["source"]=>
string(14) "massdevice.com"
["publication_date"]=>
string(10) "2023-11-07"
["categories"]=>
array(3) {
[0]=>
string(20) "Business Development"
[1]=>
string(20) "Corporate Governance"
[2]=>
string(15) "Deals & Tenders"
}
}
[1]=>
array(7) {
["title_en"]=>
string(113) "Elekta Expands Market and Treatment Application of Brachytherapy with Acquisition of iCAD, Inc.’s Xoft Business"
["snippet_en"]=>
string(299) "October 23, 2023 — Elekta announced it has acquired the Xoft business from iCAD, Inc. through an asset acquisition. By acquiring the Xoft Axxent Electronic Brachytherapy( eBx) System, together with the transfer of employees, Elekta, the world leader in brachytherapy solutions, will now be able to"
["url"]=>
string(131) "https://www.itnonline.com/content/elekta-expands-market-and-treatment-application-brachytherapy-acquisition-icad-inc%E2%80%99s-xoft"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/49929b6b-8dd7-40d2-8d60-2ddcc210ca1f"
["source"]=>
string(13) "itnonline.com"
["publication_date"]=>
string(10) "2023-10-23"
["categories"]=>
array(7) {
[0]=>
string(25) "Business Model Resilience"
[1]=>
string(15) "Market Movement"
[2]=>
string(11) "Acquisition"
[3]=>
string(21) "Competitive Behaviour"
[4]=>
string(23) "Supply Chain Management"
[5]=>
string(20) "Business Development"
[6]=>
string(18) "Expansion & Growth"
}
}
[2]=>
array(7) {
["title_en"]=>
string(48) "iCad sells Xoft brachytherapy business to Elekta"
["snippet_en"]=>
string(107) "iCad today announced it sold its Xoft Brachytherapy business line to Elekta for approximately $5.5 million."
["url"]=>
string(76) "https://www.massdevice.com/icad-sells-xoft-brachytherapy-business-to-elekta/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/81acbec2-d388-4773-a92c-c464828e836b"
["source"]=>
string(14) "massdevice.com"
["publication_date"]=>
string(10) "2023-10-23"
["categories"]=>
array(6) {
[0]=>
string(22) "Business Restructuring"
[1]=>
string(25) "Business Model Resilience"
[2]=>
string(10) "Divestment"
[3]=>
string(11) "Acquisition"
[4]=>
string(20) "Business Development"
[5]=>
string(18) "Business Structure"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(35)
}
[1]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(25)
}
[2]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(23)
}
[3]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(19)
}
[4]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(16)
}
[5]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(16)
}
[6]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(15)
}
[7]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(14)
}
[8]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(11)
}
[9]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(11)
}
[10]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(11)
}
[11]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(9)
}
[12]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(8)
}
[13]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(7)
}
[14]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(6)
}
[15]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(6)
}
[16]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(6)
}
[17]=>
array(2) {
["name"]=>
string(12) "Going Public"
["count"]=>
int(6)
}
[18]=>
array(2) {
["name"]=>
string(10) "Executives"
["count"]=>
int(5)
}
[19]=>
array(2) {
["name"]=>
string(25) "Leadership and Governance"
["count"]=>
int(5)
}
[20]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(5)
}
[21]=>
array(2) {
["name"]=>
string(18) "Ecological Impacts"
["count"]=>
int(4)
}
[22]=>
array(2) {
["name"]=>
string(21) "Shareholders Feedback"
["count"]=>
int(4)
}
[23]=>
array(2) {
["name"]=>
string(27) "Business Model & Innovation"
["count"]=>
int(4)
}
[24]=>
array(2) {
["name"]=>
string(12) "Staff hiring"
["count"]=>
int(4)
}
[25]=>
array(2) {
["name"]=>
string(17) "Energy Management"
["count"]=>
int(3)
}
[26]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(3)
}
[27]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(3)
}
[28]=>
array(2) {
["name"]=>
string(20) "Corporate Governance"
["count"]=>
int(2)
}
[29]=>
array(2) {
["name"]=>
string(21) "Intellectual Property"
["count"]=>
int(2)
}
}
}
dbe4b-gb-elekta-limited
ELEKTA LIMITED
Location
Founded
1996-09-02
Website
https://www.elekta.com
Articles
553 Articles
Category
Surgical and Medical Instruments and Apparatus
Description
At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm. Visit elekta.com to learn more.
October 23, 2023 — Elekta announced it has acquired the Xoft business from iCAD, Inc. through an asset acquisition. By acquiring the Xoft Axxent Electronic Brachytherapy( eBx) System, together with the transfer of employees, Elekta, the world leader in brachytherapy solutions, will now be able to
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.